American Journal of Ophthalmology
Volume 149, Issue 5 , Pages 699-700 , May 2010

Proof of Concept for Combined Insertion of Fluocinolone Acetonide and Glaucoma Drainage Implants for Eyes with Uveitis and Glaucoma

  • Husam Ansari

      Affiliations

    • Department of Ophthalmology, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
  • ,
  • John H. Kempen

      Affiliations

    • Department of Ophthalmology, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Department of Biostatistics and Epidemiology, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Corresponding Author InformationInquiries to John H. Kempen, Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology, University of Pennsylvania, 3535 Market St, Suite 700, Philadelphia, PA 19104

,Accepted 8 March 2010.

References 

  1. Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica. 2004;218(4):223–236
  2. National Advisory Eye Council. Vision research (A national plan, 1983–1987). In: Bethesda, MD: National Institutes of Health, Public Health Service, US Department of Health and Human Services; 1983;p. 13
  3. Panek WC, Holland GN, Lee DA, Christensen RE. Glaucoma in patients with uveitis. Br J Ophthalmol. 1990;74(4):223–227
  4. Herbert HM, Viswanathan A, Jackson H, Lightman SL. Risk factors for elevated intraocular pressure in uveitis. J Glaucoma. 2004;13(2):96–99
  5. Neri P, Azuara-Blanco A, Forrester JV. Incidence of glaucoma in patients with uveitis. J Glaucoma. 2004;13(6):461–465
  6. Takahashi T, Ohtani S, Miyata K, et al. A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol. 2002;46(5):556–562
  7. Callanan DG, Jaffe GJ, Martin DF, et al. Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol. 2008;126(9):1191–1201
  8. The Multicenter Uveitis Steroid Treatment Trial Research Group. The Multicenter Uveitis Steroid Treatment trial: rationale, design and baseline characteristics. Am J Ophthalmol. 2010;149(4):550–561
  9. Goldstein DA, Godfrey DG, Hall A, et al. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. Arch Ophthalmol. 2007;125(11):1478–1485
  10. Malone PE, Herndon LW, Muir KW, et al. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma. Am J Ophthalmol. 2010;149(5):800–807

 See Accompanying Article on page 800.

PII: S0002-9394(10)00166-2

doi: 10.1016/j.ajo.2010.03.001

American Journal of Ophthalmology
Volume 149, Issue 5 , Pages 699-700 , May 2010